This is Money

In the past few days, the country’s major banks have all published financial results that should encourage shareholders. But…

At £23.40, Morgan Sindall shares have soared by 66 per cent in the past four years and are likely to trend higher in the months…

City sources said Swiss chip company U-blox had made a last-ditch effort to mount a £320million-plus counter-offer. They said…

Rolet, former boss of the Stock Exchange, who built his career in banking, said graduates had no right to complain about working…

The UK’s second-largest defence firm said it would need to write off £2billion from the value of the business as part of a drastic…

A spineless board has convinced Fortress it ison the home straight and it can use a court-sanctioned deal to speed through the…

Fintechs, the new breed of challenger digital institution, are snapping at the heels of the mainstream banks, whose legacy IT…

William Chalmers, who is standing in as chief executive before Charlie Nunn starts next month, said the outlook was ‘more promising’…

You only have to look at the fortunes of Astrazeneca since 2014 to understand why rejecting financially driven overseas suitors…

The British drugs giant has been left in the dust by rivals during the pandemic, with Pfizer, Moderna, Johnson & Johnson and…